Exelixis Inc (EXEL)

Currency in USD
37.26
+1.04(+2.87%)
Closed·
After Hours
37.260.00(0.00%)
·

EXEL Earnings

Latest Release
Jul 28, 2025
EPS / Forecast
0.75 / 0.64
Revenue / Forecast
568.30M / 578.46M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2025--/0.682--/591.9M----Free Sign Up
06/20250.75/0.64568.3M/578.46M+17.19%-1.76%Free Sign Up
03/20250.62/0.37555.4M/495.3M+67.57%+12.13%Free Sign Up
12/20240.55/0.39566.8M/559.89M+41.03%+1.23%Free Sign Up
09/20240.47/0.34539.5M/489.77M+38.24%+10.15%Free Sign Up
06/20240.84/0.31637.2M/465.97M+170.97%+36.75%Free Sign Up
03/20240.17/0.23425M/456.83M-26.09%-6.97%Free Sign Up
12/20230.33/0.23480M/481.81M+43.48%-0.38%Free Sign Up
09/20230.1/0.15471.92M/471.64M-33.33%+0.06%Free Sign Up
06/20230.31/0.17469.8M/447.2M+82.35%+5.05%Free Sign Up

All numbers in USD

Exelixis Inc Earnings Call Summary for Q2/2025

  • Exelixis reported Q2 2025 EPS of $0.75, beating $0.64 forecast; revenue at $568M, slightly below $578.46M estimate
  • Cabozantinib franchise net product revenues grew 19% YoY; successful launch of CABOMETYX for neuroendocrine tumors
  • Company maintains full-year 2025 guidance; exploring new indications for Zanzalutinib and opportunities in meningioma
  • Shares rose 0.86% in aftermarket trading; stock up 89.8% over past year, 33.3% YTD; analysts' targets range from $36 to $60
  • CEO highlights resilience and strategic focus on careful pipeline development amid competitive oncology market
Last Updated: 28/07/2025, 23:12
Read Full Transcript

FAQ

What Is Exelixis's Earnings Per Share (TTM)?

The Exelixis EPS (TTM) is 2.15.

When Is The Next Exelixis Earnings Date?

Exelixis will release its next earnings report on 03 Nov 2025.

What Is Exelixis’s Revenue Forecasts For Upcoming Quarters?

Exelixis’s revenue forecast is 591.90M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.